Tom Frohlich
2021
In 2021, Tom Frohlich earned a total compensation of $1.9M as Chief Operating Officer at Aduro BioTech, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,333 |
|---|---|
| Option Awards | $975,513 |
| Salary | $415,171 |
| Stock Awards | $308,947 |
| Other | $1,954 |
| Total | $1,865,918 |
Frohlich received $975.5K in option awards, accounting for 52% of the total pay in 2021.
Frohlich also received $164.3K in non-equity incentive plan, $415.2K in salary, $308.9K in stock awards and $2K in other compensation.
Rankings
In 2021, Tom Frohlich's compensation ranked 6,310th out of 12,415 executives tracked by ExecPay. In other words, Frohlich earned more than 49.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,310 out of 12,415 | 49th |
Division Manufacturing | 2,687 out of 5,505 | 51st |
Major group Chemicals And Allied Products | 1,180 out of 2,375 | 50th |
Industry group Drugs | 1,050 out of 2,096 | 50th |
Industry Pharmaceutical Preparations | 760 out of 1,546 | 51st |
Source: SEC filing on April 14, 2022.
Frohlich's colleagues
We found two more compensation records of executives who worked with Tom Frohlich at Aduro BioTech in 2021.